Oncotelic Therapeutics, Inc. (OTLC): 3 insider purchases in the last two years (2 opportunistic).
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jul 10, 2025 | Trieu Vuong Director, Officer, TenPercentOwner | 198,737 | $0.01 | $2.0K | opportunistic |
| Jan 31, 2025 | Trieu Vuong Director, Officer, TenPercentOwner | 346,844 | $0.03 | $10.4K | opportunistic |
| Nov 26, 2024 | Trieu Vuong Director, Officer, TenPercentOwner | 298,499 | $0.03 | $9.0K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.